Issue 3/2009
Content (26 Articles)
Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer
Marc P. J. McCafferty, Roisin E. McNeill, Nicola Miller, Michael J. Kerin
Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysis
Davide Mauri, Antonis Valachis, Ilias P. Polyzos, Nikolaos P. Polyzos, Konstantinos Kamposioras, Lorenzo L. Pesce
Glucocorticoid receptor expression in breast cancer associates with older patient age
Larissa Belova, Bertha Delgado, Masha Kocherginsky, Amal Melhem, Olufunmilayo I. Olopade, Suzanne D. Conzen
Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas
Victoria Wargon, Luisa A. Helguero, Julieta Bolado, Paola Rojas, Virginia Novaro, Alfredo Molinolo, Claudia Lanari
Characterization of the weak estrogen receptor α agonistic activity of exemestane
Selma Masri, Ki Lui, Sheryl Phung, Jingjing Ye, Dujin Zhou, Xin Wang, Shiuan Chen
Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis
Ling Chen, Zhengmao Zhu, Xiaodong Sun, Xue-Yuan Dong, Jia Wei, Feng Gu, Yu-Lan Sun, Jun Zhou, Jin-Tang Dong, Li Fu
Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH
Simon A. Joosse, Erik H. van Beers, Ivon H. G. Tielen, Hugo Horlings, Johannes L. Peterse, Nicoline Hoogerbrugge, Marjolijn J. Ligtenberg, Lodewyk F. A. Wessels, Priscilla Axwijk, Senno Verhoef, Frans B. L. Hogervorst, Petra M. Nederlof
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93
Olivia Pagani, Shari Gelber, Edda Simoncini, Monica Castiglione-Gertsch, Karen N. Price, Richard D. Gelber, Stig B. Holmberg, Diana Crivellari, John Collins, Jurij Lindtner, Beat Thürlimann, Martin F. Fey, Elizabeth Murray, John F. Forbes, Alan S. Coates, Aron Goldhirsch
Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study
C. Falandry, M. Debled, T. Bachelot, T. Delozier, J. Crétin, P. Romestaing, D. Mille, B. You, L. Mauriac, E. Pujade-Lauraine, G. Freyer
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial
Pascal Jézéquel, Mario Campone, Henri Roché, Wilfried Gouraud, Catherine Charbonnel, Gabriel Ricolleau, Florence Magrangeas, Stéphane Minvielle, Jean Genève, Anne-Laure Martin, Régis Bataille, Loïc Campion
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer
Cynthia R. Osborne, Anita Duncan, Scot Sedlacek, Devchand Paul, Frankie Holmes, Svetislava Vukelja, Michael Kasper, Sharon Wilks, Andrew Schneider, Richard McGee, Wally G. Meyer, Joyce A. O’Shaughnessy
Does hormonal therapy decrease tamoxifen associated hot flashes?
Debra L. Barton, Charles L. Loprinzi
A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer
Andrea L. Cheville, Indra Das, Shyam Srinivas, Josh Schuerman, Luke Velders, Lawrence J. Solin, Sandip Basu, Abass Alavi
Identifying the “sentinel lymph nodes” for arm drainage as a strategy for minimizing the lymphedema risk after breast cancer therapy
Thomas A. Buchholz, Rony Avritscher, Tse-Kuan Yu
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes
Bryan P. Schneider, Milan Radovich, David A. Flockhart, Janet S. Carpenter, Lang Li, Jason D. Robarge, Anna M. Storniolo, Bradley A. Hancock, Todd C. Skaar, George W. Sledge
Alcohol and folate intake and breast cancer risk in the WHI Observational Study
Christine M. Duffy, Annlouise Assaf, Michele Cyr, Gary Burkholder, Elizabeth Coccio, Tom Rohan, Anne McTiernan, Electra Paskett, Dorothy Lane, V. K. Chetty
Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients
Nan-Yan Rao, Zhen Hu, Jin-Ming Yu, Wen-Feng Li, Bin Zhang, Feng-Xi Su, Jiong Wu, Zhen-Zhou Shen, Wei Huang, Zhi-Ming Shao
CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis
Cheng Lu, Jing Dong, Hongxia Ma, Guangfu Jin, Zhibin Hu, Yuzhu Peng, Xirong Guo, Xinru Wang, Hongbing Shen
BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy
Laura Ottini, Piera Rizzolo, Ines Zanna, Mario Falchetti, Giovanna Masala, Ketty Ceccarelli, Vania Vezzosi, Alberto Gulino, Giuseppe Giannini, Simonetta Bianchi, Francesco Sera, Domenico Palli
Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States
Charlotte Atkinson, Katherine M. Newton, Erin J. Aiello Bowles, Constance D. Lehman, Frank Z. Stanczyk, Kim C. Westerlind, Lin Li, Johanna W. Lampe
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
James J. Dignam, Vanja Dukic, Stewart J. Anderson, Eleftherios P. Mamounas, D. Lawrence Wickerham, Norman Wolmark
Increasing incidence of breast cancer: distinguishing between the effects of birth cohort and a national breast screening programme
Sylvia B. F. Brown, David S. Morrison, Timothy G. Cooke
Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them
Eunmi Ahn, Juhee Cho, Dong Wook Shin, Byeong Woo Park, Sei Hyun Ahn, Dong-Young Noh, Seok Jin Nam, Eun Sook Lee, Young Ho Yun
Caution should be taken in the methodology used to confirm c.156_157insAlu BRCA2 mutation
Patricia Machado, Fatima Vaz
Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer
Aydan Eroglu, Ragip Çam, Yonca Eğin, Nejat Akar
About the c.156_157insAlu BRCA2 breast cancer predisposing mutation
Erik Teugels, Jacques De Grève